These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 8213289)

  • 21. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine in the treatment of anger: an open clinical trial.
    Rubey RN; Johnson MR; Emmanuel N; Lydiard RB
    J Clin Psychiatry; 1996 Sep; 57(9):398-401. PubMed ID: 9746447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine: sources of variability and preliminary observations on relations with clinical response.
    Jannuzzi G; Gatti G; Magni P; Spina E; Pacifici R; Zuccaro P; Torta R; Guarneri L; Perucca E
    Ther Drug Monit; 2002 Oct; 24(5):616-27. PubMed ID: 12352933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with fluoxetine and norfluoxetine plasma concentrations and clinical response in Mexican patients with mental disorders.
    Sagahón-Azúa J; Medellín-Garibay SE; Chávez-Castillo CE; González-Salinas CG; Milán-Segovia RDC; Romano-Moreno S
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00864. PubMed ID: 34523245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between antidepressant response and plasma concentrations of fluoxetine and norfluoxetine.
    Norman TR; Gupta RK; Burrows GD; Parker G; Judd FK
    Int Clin Psychopharmacol; 1993; 8(1):25-9. PubMed ID: 8473717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluoxetine: relations between plasma concentration and therapeutic effects in 32 patients with major depression and treated with 20 mg/day].
    Bourdeaux R; Pannetier P; Younos C; Desor D; Lehr PR; Capolaghi B
    Encephale; 1998; 24(1):57-61. PubMed ID: 9559305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of fluoxetine in elderly men and women.
    Ferguson JM; Hill H
    Gerontology; 2006; 52(1):45-50. PubMed ID: 16439824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1992 Apr; 53(4):127-9. PubMed ID: 1564047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine treatment of self-injurious behavior in mentally retarded patients.
    Markowitz PI
    J Clin Psychopharmacol; 1990 Aug; 10(4):299-300. PubMed ID: 2286704
    [No Abstract]   [Full Text] [Related]  

  • 30. [Multidimensional pharmacopsychiatry in gerontopsychiatry: studies on the therapy with tricyclic antidepressant drugs (author's transl)].
    Bergener M; Hesse C; Hummel F; Husser J; Kern U
    Aktuelle Gerontol; 1976 Jul; 6(7):357-64. PubMed ID: 14541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoxetine pharmacokinetics in pediatric patients.
    Wilens TE; Cohen L; Biederman J; Abrams A; Neft D; Faird N; Sinha V
    J Clin Psychopharmacol; 2002 Dec; 22(6):568-75. PubMed ID: 12454556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine.
    Bergstrom RF; Beasley CM; Levy NB; Blumenfield M; Lemberger L
    Int Clin Psychopharmacol; 1993; 8(4):261-6. PubMed ID: 8277145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fluoxetine hydrochloride].
    Schifano F
    G Clin Med; 1990 Feb; 71(2):141-4. PubMed ID: 2347460
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluoxetine-associated side effects and suicidality.
    Morton WA; Sonne SC; Lydiard RB
    J Clin Psychopharmacol; 1993 Aug; 13(4):292-5. PubMed ID: 8166790
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluoxetine inhibition of phenytoin metabolism.
    Shader RI; Greenblatt DJ; von Moltke LL
    J Clin Psychopharmacol; 1994 Dec; 14(6):375-6. PubMed ID: 7884016
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of side-effects in psychopharmacological experiments].
    Himmelmann GW; Ihm P; Tücke M; Martin H; Spiegelberg U
    Arzneimittelforschung; 1971 May; 21(5):625-8. PubMed ID: 5109686
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical pharmacology and pharmacokinetics of fluoxetine: a review.
    Bergstrom RF; Lemberger L; Farid NA; Wolen RL
    Br J Psychiatry Suppl; 1988 Sep; (3):47-50. PubMed ID: 3074865
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined fluoxetine and tricyclic antidepressants.
    Rudorfer MV; Potter WZ
    Am J Psychiatry; 1989 Apr; 146(4):562-4. PubMed ID: 2784634
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapeutic effects of PC 63-14 in psychiatric practice].
    Bouvier C; Masquin A
    Lyon Med; 1969 Jun; 221(26):1561-4. PubMed ID: 5363736
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of Tisercin and its combinations in ambulatory psychiatric practice].
    Hárdi I; Saághy M
    Orv Hetil; 1967 Jul; 108(27):1263-6. PubMed ID: 6076092
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.